VLDLR Antikörper (AA 231-770)
Kurzübersicht für VLDLR Antikörper (AA 231-770) (ABIN7872569)
Target
Alle VLDLR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 231-770
-
Verwendungszweck
- VLDL Receptor Antibody / VLDLR
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids R231-S770) was used as the immunogen for the VLDL Receptor antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the VLDL Receptor antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the VLDL Receptor antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
Andere Bezeichnung
- VLDL Receptor
-
Hintergrund
- The very-low-density-lipoprotein receptor (VLDLR) is a transmembrane lipoprotein receptor of the low-density-lipoprotein (LDL) receptor family. The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.
-
UniProt
- P98155
-
Pathways
- Cellular Response to Molecule of Bacterial Origin
Target
-